INGN - Inogen, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Inogen, Inc.

326 Bollay Drive
Goleta, CA 93117
United States

IndustryMedical Devices
Full Time Employees1,099

Key Executives

NameTitlePayExercisedYear Born
Mr. Scott WilkinsonCEO, Pres & Director937.49k4.19M1965
Mr. Brenton TaylorCo-founder & Exec. VP of Engineering474.86k9.05M1981
Ms. Alison Perry BauerleinCo-founder, Exec. VP of Fin., CFO, Corp. Sec. & Treasurer542.58k11.11M1981
Mr. Bart SanfordExec. VP of Operations431.47kN/A1966
Mr. Byron MyersExec. VP of Sales & Marketing473.64k9.2M1979
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.

Corporate Governance

Inogen, Inc.’s ISS Governance QualityScore as of October 4, 2019 is 8. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 8; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.